Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis

Researchers from Skoltech contributed to a large study made by colleagues from Pirogov Russian National Research Medical University, Shemyakin-Ovchinnikov Institute of bioorganic chemistry and other universities and organizations. The article, published in the Nature Medicine journal, presents an innovative treatment for ankylosing spondylitis.